0001127602-23-011750.txt : 20230403 0001127602-23-011750.hdr.sgml : 20230403 20230403101305 ACCESSION NUMBER: 0001127602-23-011750 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230330 FILED AS OF DATE: 20230403 DATE AS OF CHANGE: 20230403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirchgraber Paul R CENTRAL INDEX KEY: 0001791393 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 23791118 MAIL ADDRESS: STREET 1: 531 SOUTH SPRING STREET CITY: BURLINGTON STATE: NC ZIP: 27215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 4 1 form4.xml PRIMARY DOCUMENT X0407 4 2023-03-30 0000920148 LABORATORY CORP OF AMERICA HOLDINGS LH 0001791393 Kirchgraber Paul R 531 SOUTH SPRING STREET BURLINGTON NC 27215 1 CEO, Covance Drug Development 0 Common Stock 2023-03-30 4 A 0 6763 0 A 15832 D Common Stock 2023-03-30 4 F 0 2886 224.70 D 12946 D Shares acquired on March 30, 2023, pursuant to a performance award granted on February 4, 2020, relating to performance during the three-year period ended December 31, 2022. Stock withholding to satisfy tax withholding obligations. /s/ Sandra van der Vaart, Attorney-in-Fact for Paul R. Kirchgraber 2023-04-03